Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid an... read more Featured Products: More products

Download Mobile App




Study Demonstrates Advantages of AI for Digital Breast Tomosynthesis

By HospiMedica International staff writers
Posted on 25 Oct 2018
A study of digital breast tomosynthesis (DBT) cancer detection software by iCAD, Inc. More...
(Nashua, NH, USA) has demonstrated unprecedented improvements in clinical performance and reading times, validating the substantial benefits of Artificial Intelligence (AI) when used with three-dimensional (3D) mammography.

iCAD, a provider of cancer detection and therapy solutions, has developed a cancer detection and workflow solution for breast tomosynthesis that delivers critical benefits to both radiologists and their patients. The new technology is trained to detect malignancies and determine the probability of malignant findings, providing radiologists with a “certainty of finding” score for each case and each detected lesion. These scores represent the algorithm’s confidence that the detected soft tissue densities (masses, architectural distortions and asymmetries) and calcifications are malignant.

iCAD’s latest study of its DBT cancer detection software demonstrated significant positive results for clinical performance and workflow efficiency. The findings confirmed that the latest AI software solution to support DBT increased improvements in both reader sensitivity (8% on average) and specificity (6.9% on average). Additionally, when reading tomosynthesis cases with the solution, the study found that the reading times of radiologists were reduced by more than half (52.7% on average).

“As incidence rates of breast cancer continue to rise, we are proud to provide valuable technology that is proven to significantly improve detection rates while reducing unnecessary recalls resulting from false positives. We also understand that radiologists are concerned about the extra workload and long reading times of tomosynthesis cases in everyday practice and we are pleased to have created a meaningful solution to address this problem,” said Jeff Hoffmeister, MD, Vice President and Medical Director at iCAD. “As tomosynthesis moves into the screening arena, our AI software provides important benefits to radiologists, their practices, and their patients.”


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Morcellator
TCM 3000 BL
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.